Sze-Ting Lee

15PUBLICATIONS
134CO-AUTHORS
Haematological tumoursPredictive and prognostic markersRadiation therapyIsotope geochemistryProfessional ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 10, 2026
A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastoma.

|Apr 28, 2026
177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer.

|Feb 06, 2026
Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Aslı D Munzur, Cameron Herberts, Edmond M Kwan

|Nov 13, 2025
Radioligand Therapy in Cancer Management: A Global Perspective.

Gaia Ninatti, Sze Ting Lee, Andrew M Scott

|Oct 08, 2025
False Positive Findings of 68Ga-DOTATOC PET/CT: A Systematic Review.

Dhuha Al-Adhami, Ahmed Saad Abdlkadir, Sze Ting Lee

|Jun 27, 2025
Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI.

Jack O'Shaughnessy, Arina Martynchyk, Sze Ting Lee

Pageof 3

Frequent Collaborators

8 joint publications

Andrew M Scott

3 joint publications

Akram Naif Al-Ibraheem

3 joint publications

Roslyn J Francis

2 joint publications

Diana Paez